11th Circ. Undermined Rare-Disease Drugs, High Court Told
By Adam Lidgett · April 12, 2022, 7:27 PM EDT
Jacobus Pharmaceutical Co. Inc. said that the Eleventh Circuit created a circuit split and upended years of U.S. Food and Drug Administration policy when it ruled lucrative exclusivity for so-called orphan...
To view the full article, register now.